| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 132, 459-467, Copyright © 1993 by Endocrine Society
ARTICLES |
E Arzt, R Buric, G Stelzer, J Stalla, J Sauer, U Renner and GK Stalla
Max Planck Institute of Psychiatry, Clinical Institute, Munich, Germany.
The pituitary gland plays a central role in the interactions between the immune and neuroendocrine systems. The expression of receptors for interleukin-1 (IL-1), IL-2, and IL-6 and the intrinsic production of these ILs by pituitary cells have been described. Previous studies have focused on the way cytokines influence hormone secretion. We have determined whether, in addition to these effects, ILs could affect pituitary cell proliferation. In GH3 cells, both IL-2 (1-100 U/ml) and IL-6 (10-500 U/ml) significantly stimulated [3H]thymidine incorporation and cell count. In contrast, inhibitory effects of both IL-2 and IL-6 at the same concentrations were observed on normal rat anterior pituitary cell growth. This finding was clearly evident when cells were cultured in Minimum Essential Medium-D-valine medium, a condition that results in cultures virtually free of fibroblasts. Autoradiographic studies confirmed that [3H]thymidine was only incorporated in the nucleus of nonfibroblastic pituitary cells. No direct correlation between the effects of IL-2 and IL-6 on cell growth and hormone secretion was apparent. By immunofluorescence, we observed IL-2 receptor expression on GH3 cells and, for the normal rat cultures, a high percentage of PRL-secreting and a lower percentage of GH-producing cells expressing IL-2 receptors, providing new evidence for a direct site of action of IL-2 on pituitary cells. Considering that uncontrolled division of cells may result from either excessive growth stimulation or deficient growth inhibition, the regulation of pituitary cell growth by IL-2 and IL-6 together with their intrinsic pituitary production could be of potential importance in pituitary adenoma pathogenesis.
This article has been cited by other articles:
![]() |
J. Gerez, J. Bonfiglio, S. Sosa, D. Giacomini, M. Acuna, A. Carbia Nagashima, M. J. Perone, S. Silberstein, U. Renner, G. K. Stalla, et al. Molecular transduction mechanisms of cytokine-hormone interactions: role of gp130 cytokines Exp Physiol, September 1, 2007; 92(5): 801 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishida, W. Takahashi, S. Itoh, S. Shimodaira, S. Maeda, and J. Arita Estrogen Actions on Lactotroph Proliferation Are Independent of a Paracrine Interaction with Other Pituitary Cell Types: A Study Using Lactotroph-Enriched Cells Endocrinology, July 1, 2007; 148(7): 3131 - 3139. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Refojo, C. Echenique, M. B. Muller, J. M. H. M. Reul, J. M. Deussing, W. Wurst, I. Sillaber, M. Paez-Pereda, F. Holsboer, and E. Arzt Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas PNAS, April 26, 2005; 102(17): 6183 - 6188. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Borg, K. E. Kerry, L. Baxter, J. A. Royds, and T. H. Jones Expression of Interleukin-6 and Its Effects on Growth of HP75 Human Pituitary Tumor Cells J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4938 - 4944. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Paez-Pereda, D. Giacomini, D. Refojo, A. C. Nagashima, U. Hopfner, Y. Grubler, A. Chervin, V. Goldberg, R. Goya, S. T. Hentges, et al. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk PNAS, February 4, 2003; 100(3): 1034 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Castro, D. Giacomini, A. C. Nagashima, C. Onofri, M. Graciarena, K. Kobayashi, M. Paez-Pereda, U. Renner, G. K. Stalla, and E. Arzt Reduced Expression of the Cytokine Transducer gp130 Inhibits Hormone Secretion, Cell Growth, and Tumor Development of Pituitary Lactosomatotrophic GH3 Cells Endocrinology, February 1, 2003; 144(2): 693 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Castro, A. C. Nagashima, M. P. Pereda, V. Goldberg, A. Chervin, P. Largen, U. Renner, G. K. Stalla, and E. Arzt The gp130 Cytokines Interleukin-11 and Ciliary Neurotropic Factor Regulate through Specific Receptors the Function and Growth of Lactosomatotropic and Folliculostellate Pituitary Cell Lines Endocrinology, May 1, 2000; 141(5): 1746 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Pereda, M. F. Ledda, V. Goldberg, A. Chervín, G. Carrizo, H. Molina, A. Müller, U. Renner, O. Podhajcer, E. Arzt, et al. High Levels of Matrix Metalloproteinases Regulate Proliferation and Hormone Secretion in Pituitary Cells J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 263 - 269. [Abstract] [Full Text] |
||||
![]() |
L. Jin, B. G. Burguera, M. E. Couce, B. W. Scheithauer, J. Lamsan, N. L. Eberhardt, E. Kulig, and R. V. Lloyd Leptin and Leptin Receptor Expression in Normal and Neoplastic Human Pituitary: Evidence of a Regulatory Role for Leptin on Pituitary Cell Proliferation J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2903 - 2911. [Abstract] [Full Text] |
||||
![]() |
C. P. Castro, R. Peñalva, M. P. Pereda, U. Renner, J. M. H. M. Reul, G. K. Stalla, F. Holsboer, and E. Arzt Early Activation of Thyrotropin-Releasing-Hormone and Prolactin Plays a Critical Role during a T Cell-Dependent Immune Response Endocrinology, February 1, 1999; 140(2): 690 - 697. [Abstract] [Full Text] |
||||
![]() |
A. O. L. Wong, M. Y. Leung, W. L. C. Shea, L. Y. Tse, J. P. Chang, and B. K. C. Chow Hypophysiotropic Action of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Goldfish: Immunohistochemical Demonstration of PACAP in the Pituitary, PACAP Stimulation of Growth Hormone Release from Pituitary Cells, and Molecular Cloning of Pituitary Type I PACAP Receptor Endocrinology, August 1, 1998; 139(8): 3465 - 3479. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sauer, U. Renner, U. Hopfner, M. Lange, A. Müller, C. J. Strasburger, U. Pagotto, E. Arzt, and G. K. Stalla Interleukin-1{beta} Enhances Interleukin-1 Receptor Antagonist Content in Human Somatotroph Adenoma Cell Cultures J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2429 - 2434. [Abstract] [Full Text] |
||||
![]() |
B. L. Spangelo, D. D. Farrimond, M. Thapa, C. M. Bulathsinghala, K.-L. Bowman, A. Sareh, F. M. Hughes Jr., A. L. Goldstein, and M. Badamchian Thymosin Fraction 5 Inhibits the Proliferation of the Rat Neuroendocrine MMQ Pituitary Adenoma and C6 Glioma Cell Lines in Vitro Endocrinology, April 1, 1998; 139(4): 2155 - 2162. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Jones, S. K. Justice, and A. Price Suppression of Tyrosine Kinase Activity Inhibits [3H]Thymidine Uptake in Cultured Human Pituitary Tumor Cells J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2143 - 2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text] |
||||
![]() |
S. E Walker, S. H Allen, R. W Hoffman, and R. W McMurray Review : Prolactin: a stimulator of disease activity in systemic lupus erythematosus Lupus, February 1, 1995; 4(1): 3 - 9. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |